Moffitt Science Debuts at Largest Cancer Conference

By Staff Writer - May 15, 2020

Every May, the best and brightest in oncology come together for the American Society of Clinical Oncology (ASCO) Annual Meeting, one of the largest scientific conferences in the world. More than 40,000 experts in every cancer type from around the world participate. The goal of the multiday meeting is to share the latest clinical trials and science advancing the treatment, diagnosis and prevention of cancer. It is where we learn the future of cancer care.

Due to the COVID-19 pandemic, this year’s meeting will be virtual and feature a variety of on-demand scientific content that coincides with the theme, “Unite and Conquer: Accelerating Progress Together.” Advances in immunotherapies and targeted therapies for lung, colorectal, ovarian and bladder cancers; improvements in access to cancer care; and the impact of COVID-19 on cancer patients are among the topics that will be highlighted during this year’s meeting.

Moffitt Cancer Center will once again be well represented at the ASCO Annual Meeting. Our faculty are authors on more than 100 of the approximately 2,215 abstracts accepted for the scientific program. The studies our scientists are presenting cover more than 25 different cancer types and include treatment advances such as cellular immunotherapy, which uses a patient’s own immune cells to fight their disease.

Read Moffitt's ASCO 2020 Stories

Speeding Up Cellular Immunotherapy
New ‘off the shelf' CAR T product shows promise in phase 1 study


New Immunotherapy for Advanced Melanoma
Lifileucel offers hope for metastatic melanoma patients who fail approved treatment


Integrated Management of Older Cancer Patients Changes Outcomes
New studies show better results for geriatric patients


Stereotactic Body Radiation Offers New Option for Head and Neck Cancer
Moffitt study shows high-dose radiation offers shorter treatment with good outcomes


Drug Improves Survival in Relapsed Ovarian Cancer Patients with BRCA Mutation
Maintenance therapy with olaparib extended survival by more than a year


It’s Never Too Late to Kick the Habit
New study shows quitting smoking even two years before lung cancer diagnosis improves survival


Subscribe

Most Popular